Accretion Nutraveda IPO
GMP, Subscription, Price, Dates & Financial Details
Trading
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products across a wide range of dosage forms, including tablets, capsules, oral liquids, powders, oils, and external applications such as balms, creams, and gels.The Company operates as a…
Open Date
Wed, 28 Jan 2026
Close Date
Fri, 30 Jan 2026
Price Band
₹ 122 – 129
Lot Size
1000
Issue Size
₹ 25.00 Cr
Minimum Investment
₹ 258,000 (2000 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Accretion Nutraveda IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹25.00 Crore.
The Accretion Nutraveda IPO remained open for subscription from January 28, 2026, to January 30, 2026. The basis of allotment was finalized on February 02, 2026, and the company's shares were listed on BSE SME Platform on February 04, 2026.
The company had fixed the price band at ₹122 to ₹129 per share, with a lot size of 1000 shares. Retail investors were required to make a minimum investment of ₹258,000 (based on the upper price band) to apply for one lot.
KFin Technologies Limited served as the registrar to the issue. Sobhagya Capital Options Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Accretion Nutraveda Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Accretion Nutraveda IPO Timeline (Tentative)
- IPO Open Date
- Wed, 28 Jan 26
- IPO Close Date
- Fri, 30 Jan 26
- Basis of Allotment
- Mon, 02 Feb 26
- Initiation of Refunds
- Tue, 03 Feb 26
- Credit of Shares to Demat
- Tue, 03 Feb 26
- Listing Date
- Wed, 04 Feb 26 — NSE & BSE
Open Date
28 January 2026
Close Date
30 January 2026
Basis Of Allotment
02 February 2026
Listing Date
04 February 2026
IPO Subscription
Check Live Subscription →The Accretion Nutraveda IPO has received bids for 24,40,000 shares against 12,80,000 shares offered, resulting in an overall subscription of 1.91x. the NII category is subscribed 2.42x, Retail Investors 2.19x, and QIBs 1.01x.
QIB
1.01x
NII
2.42x
RII
2.19x
Total
1.91x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 6,40,000 shares, representing 50% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 3,64,000 shares (28.44%), while Non-Institutional Investors (NIIs) receive 2,76,000 shares (21.56%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 364,000 | 28.44% |
| Non-Institutional | 276,000 | 21.56% |
| BNII | 184,000 | 14.38% |
| SNII | 92,000 | 7.19% |
| Retail Investors | 640,000 | 50% |
| Total | 1,280,000 | 100% |
Financials Details(₹ in Crores)
| Particular | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 16.35 | 10.86 | 4.64 | 4.06 |
| Revenue | 14.07 | 16.06 | 5.2 | 3.07 |
| Profit After Tax | 2.33 | 2.61 | 0.82 | 0.28 |
| Net Worth | 8.26 | 5.35 | 1.08 | 0.26 |
| Reserve & Surplus | 2.95 | 4.86 | 0.72 | -0.1 |
| Total Borrowings | 4.43 | 3.86 | 2.17 | 1.97 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Accretion Nutraveda Limited KPI Information
| Particular | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 68.54 | 81.22 | 121.94 | 228.56 |
| ROCE % | 49.09 | 36.98 | 28.98 | 12.51 |
| Debt / Equity | 0.54 | 0.72 | 2 | 7.5 |
| RoNW % | 56.5 | 48.85 | 75.75 | 106.66 |
| Pat Margin % | 16.59 | 16.33 | 16.42 | 9.67 |
Peers Comparison
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Accretion Nutraveda Ltd | 10 | 0.00 | 4.73 | 4.73 | 56.50 | 16.74 |
| Walpar Nutritions Ltd. | 10 | 3.30 | 1.06 | 1.06 | 6.24 | 17.05 |
| Influx Healthtech Ltd | 10 | 46.99 | 4.81 | 4.81 | 11.10 | 38.98 |
About Accretion Nutraveda Limited
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products across a wide range of dosage forms, including tablets, capsules, oral liquids, powders, oils, and external applications such as balms, creams, and gels.
The Company operates as a Contract Development and Manufacturing Organization (CDMO), catering to both domestic and international markets. Its international presence spans countries such as Sri Lanka, Singapore, and the United States of America.
Accretion Nutraveda integrates classical Ayurvedic principles with contemporary nutraceutical science to develop products targeting key therapeutic and wellness segments, including:
- Liver care
- Women’s health
- Bone and joint health
- Cognitive health
- Respiratory wellness
Business Verticals
- Domestic Sales and Merchant Exports (Loan License Basis):
This vertical remains the primary revenue contributor, accounting for 96.62% of total revenue in FY 2024–25. - Direct Exports:
Direct exports contributed 38% of revenue, demonstrating consistent growth and reflecting the Company’s expanding international footprint.
Manufacturing Infrastructure
Accretion Nutraveda operates a state-of-the-art manufacturing facility in Gujarat, spread across approximately 10,763 square feet. The facility is equipped with modern infrastructure, including:
- 13 Air Handling Units (AHUs)
- Segregated processing areas for different product categories
- Dedicated quality control and quality assurance systems
The manufacturing unit complies with stringent regulatory and quality standards and holds the following certifications:
- GMP and WHO-GMP
- FSSC 22000
- ISO 9001:2015
- ISO 45001:2018
- Halal Certification
- FSSAI License
Accretion Nutraveda IPO Promoters
- Mr. Mayur Popatlal Sojitra
- Mr. Ankurkumar Shantilal Patel
- Mr. Paraskumar Vinubhai Parmar
- Mr. Hardik Mukundbhai Prajapati
- Mr. Harshad Nanubhai Rathod
- Mr. Vivek Ashok Kumar Patel
Promoters Holding
Holding Pre Issue
100.00%
Holding Post Issue
73.48%
Accretion Nutraveda IPO Objective
The Company Accretion Nutraveda IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Purchase of Machineries for Automation in existing Manufacturing unit
- Purchase of Machineries for New Manufacturing Setup
- Funding working capital requirements of our company
- General corporate purpose
Accretion Nutraveda Limited Address / Contact Details
Accretion Nutraveda Ltd.
27 Xcelon Industrial Park-1
Vasna-Chacharwadi, TaSanand,
Ahmedabad, Gujarat, 382213
Phone: +91- 9904366177
Email: compliance@accretionnutraveda.com
Website: http://www.accretionnutraveda.com/
IPO Snapshot
Accretion Nutraveda IPO Lot Size
The Accretion Nutraveda IPO has a lot size of 1,000 shares. Retail investors require a minimum investment of ₹2,58,000 by applying for 2 lot (2,000 shares). The maximum application allowed for the retail category is 2 lots (2,000 shares), requiring an investment of ₹2,58,000.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | 258,000.00 |
| Retail (Max) | 2 | 2,000 | 258,000.00 |
| S-HNI (Min) | 3 | 3,000 | 387,000.00 |
| S-HNI (Max) | 7 | 7,000 | 903,000.00 |
| B-HNI (Min) | 8 | 8,000 | 1,032,000.00 |
Issue Reservation
- QIB — 28.44%
- NII — 21.56%
- RII — 50%
Book Running Lead Managers
- Sobhagya Capital Options Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Accretion Nutraveda IPO?
Accretion Nutraveda IPO is a Book-building IPO with a total issue size of ₹25 crore. The Accretion Nutraveda IPO price band is ₹122 to 129 per share. The Accretion Nutraveda IPO subscription opens on Wed, Jan 28, 2026, and closes on Fri, Jan 30, 2026. The Accretion Nutraveda IPO will be listed on the BSE. KFin Technologies Limited is the registrar for the Accretion Nutraveda IPO.
When will the Accretion Nutraveda IPO open for subscription?
The Accretion Nutraveda IPO opens on Wed, Jan 28, 2026 and closes on Fri, Jan 30, 2026
What is Accretion Nutraveda IPO Price Band?
Accretion Nutraveda IPO Price Band is ₹122 to 129 per share.
What is Accretion Nutraveda IPO Lot Size?
Accretion Nutraveda IPO lot size is 1000 shares, Retail investors need a minimum investment of ₹258000 based on the upper price band
What is the minimum investment for Accretion Nutraveda IPO?
The minimum investment for Accretion Nutraveda IPO is ₹258000, based on one lot of 1000 shares at the upper price band of ₹129 per share.
How to apply for Accretion Nutraveda IPO?
Investors can apply for the Accretion Nutraveda IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jan 30, 2026. The application amount remains blocked until the Accretion Nutraveda IPO allotment is finalized.
What is Accretion Nutraveda IPO Issue Size?
Accretion Nutraveda IPO issue size is ₹25 crores.
What is the Accretion Nutraveda IPO Allotment Date?
Accretion Nutraveda IPO allotment date is Mon, Feb 2, 2026.
Who is the Accretion Nutraveda IPO Registrar?
The registrar for Accretion Nutraveda IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited website to check Accretion Nutraveda IPO allotment status, refund processing, and other IPO-related information.
What is the Accretion Nutraveda IPO GMP?
The Accretion Nutraveda IPO GMP (Grey Market Premium) is ₹68 as of Wed, Feb 4, 2026. Based on the upper price band of ₹129 per share, the estimated Accretion Nutraveda IPO listing price is ₹197, indicating a potential listing gain of approximately 52.71% over the issue price.
Who is the Accretion Nutraveda IPO Lead Manager?
The book-running lead managers (BRLMs) for the Accretion Nutraveda IPO are Sobhagya Capital Options Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Accretion Nutraveda IPO Red Herring Prospectus (RHP).